2020 ICD-10-CM Diagnosis Code C83.8

Other non-follicular lymphoma

    2016 2017 2018 2019 2020 Non-Billable/Non-Specific Code
  • C83.8 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.
  • The 2020 edition of ICD-10-CM C83.8 became effective on October 1, 2019.
  • This is the American ICD-10-CM version of C83.8 - other international versions of ICD-10 C83.8 may differ.
Applicable To
  • Intravascular large B-cell lymphoma
  • Lymphoid granulomatosis
  • Primary effusion B-cell lymphoma
Type 1 Excludes
Type 1 Excludes Help
A type 1 excludes note is a pure excludes. It means "not coded here". A type 1 excludes note indicates that the code excluded should never be used at the same time as C83.8. A type 1 excludes note is for used for when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.
  • mediastinal (thymic) large B-cell lymphoma (
    ICD-10-CM Diagnosis Code C85.2

    Mediastinal (thymic) large B-cell lymphoma

      2016 2017 2018 2019 2020 Non-Billable/Non-Specific Code
    C85.2-
    )
  • T-cell rich B-cell lymphoma (
    ICD-10-CM Diagnosis Code C83.3

    Diffuse large B-cell lymphoma

      2016 2017 2018 2019 2020 Non-Billable/Non-Specific Code
    Applicable To
    • Anaplastic diffuse large B-cell lymphoma
    • CD30-positive diffuse large B-cell lymphoma
    • Centroblastic diffuse large B-cell lymphoma
    • Diffuse large B-cell lymphoma, subtype not specified
    • Immunoblastic diffuse large B-cell lymphoma
    • Plasmablastic diffuse large B-cell lymphoma
    • Diffuse large B-cell lymphoma, subtype not specified
    • T-cell rich diffuse large B-cell lymphoma
    Type 1 Excludes
    • mediastinal (thymic) large B-cell lymphoma (C85.2-)
    • mature T/NK-cell lymphomas (C84.-)
    C83.3-
    )
The following code(s) above C83.8 contain annotation back-references
Annotation Back-References
In this context, annotation back-references refer to codes that contain:
  • Applicable To annotations, or
  • Code Also annotations, or
  • Code First annotations, or
  • Excludes1 annotations, or
  • Excludes2 annotations, or
  • Includes annotations, or
  • Note annotations, or
  • Use Additional annotations
that may be applicable to C83.8:
  • C00-D49
    2020 ICD-10-CM Range C00-D49

    Neoplasms

    Note
    • Functional activity
    • All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
    • Morphology [Histology]
    • Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
    • Primary malignant neoplasms overlapping site boundaries
    • A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
    • Malignant neoplasm of ectopic tissue
    • Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
    Neoplasms
  • C81-C96
    2020 ICD-10-CM Range C81-C96

    Malignant neoplasms of lymphoid, hematopoietic and related tissue

    Type 2 Excludes
    • Kaposi's sarcoma of lymph nodes (C46.3)
    • secondary and unspecified neoplasm of lymph nodes (C77.-)
    • secondary neoplasm of bone marrow (C79.52)
    • secondary neoplasm of spleen (C78.89)
    Malignant neoplasms of lymphoid, hematopoietic and related tissue
  • C83
    ICD-10-CM Diagnosis Code C83

    Non-follicular lymphoma

      2016 2017 2018 2019 2020 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • personal history of non-Hodgkin lymphoma (Z85.72)
    Non-follicular lymphoma
Clinical Information
  • A neoplastic lymphoproliferative process characterized by an angiocentric arrangement of the tumor cells which is associated with angiodestruction. It includes lymphomatoid granulomatosis which is a lymphoproliferative lesion derived from mature b-lymphocytes and cases of extranodal nk/t-cell lymphomas of nasal type.
  • A rare extranodal b-cell non-hodgkin lymphoma, characterized by the presence of lymphoma cells exclusively in the lumina of small vessels, particularly capillaries. This is an extremely aggressive lymphoma which responds poorly to chemotherapy. (who, 2001)
  • An angiocentric and angiodestructive lymphoproliferative disease involving extranodal sites, comprised of epstein-barr virus (ebv)-positive b-cells admixed with reactive t-cells. Incidence is higher among adult males; patients with a history of immunodeficiency are at increased risk. The most common site of involvement is the lung; other common sites include brain, kidney, liver, and skin. Morphologically, three grades are recognized: grade i, ii, and iii. Grade iii lymphomatoid granulomatosis should be approached clinically as a subtype of diffuse large b-cell lymphoma.
  • An angiocentric and angiodestructive lymphoproliferative disorder primarily involving the lungs. It is caused by an epstein-barr virus-induced transformation of the b-cells, in a t-cell rich environment. Clinically and pathologically it resembles extranodal nk-t-cell lymphoma.
  • Destructive growth of lymph cells, usually involving the lungs, skin, kidneys, and central nervous system. Grades i and ii are not considered cancerous, but grade iii is considered a lymphoma.
Code History
  • 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
  • 2017 (effective 10/1/2016): No change
  • 2018 (effective 10/1/2017): No change
  • 2019 (effective 10/1/2018): No change
  • 2020 (effective 10/1/2019): No change

Diagnosis Index entries containing back-references to C83.8:
  • Granulomatosis L92.9
    ICD-10-CM Diagnosis Code L92.9

    Granulomatous disorder of the skin and subcutaneous tissue, unspecified

      2016 2017 2018 2019 2020 Billable/Specific Code
    Type 2 Excludes
    • lymphoid C83.8-
  • Lymphoma (of) (malignant) C85.90
    ICD-10-CM Diagnosis Code C85.90

    Non-Hodgkin lymphoma, unspecified, unspecified site

      2016 2017 2018 2019 2020 Billable/Specific Code
    • non-follicular (diffuse) C83.9-
      ICD-10-CM Diagnosis Code C83.9-

      Non-follicular (diffuse) lymphoma, unspecified

        2016 2017 2018 2019 2020 Non-Billable/Non-Specific Code
      • specified NEC C83.8-
    • intravascular large B-cell C83.8-
    • primary effusion B-cell C83.8-

ICD-10-CM Codes Adjacent To C83.8
C83.70 …… unspecified site
C83.71 …… lymph nodes of head, face, and neck
C83.72 …… intrathoracic lymph nodes
C83.73 …… intra-abdominal lymph nodes
C83.74 …… lymph nodes of axilla and upper limb
C83.75 …… lymph nodes of inguinal region and lower limb
C83.76 …… intrapelvic lymph nodes
C83.77 …… spleen
C83.78 …… lymph nodes of multiple sites
C83.79 …… extranodal and solid organ sites
C83.8 Other non-follicular lymphoma
C83.80 …… unspecified site
C83.81 …… lymph nodes of head, face, and neck
C83.82 …… intrathoracic lymph nodes
C83.83 …… intra-abdominal lymph nodes
C83.84 …… lymph nodes of axilla and upper limb
C83.85 …… lymph nodes of inguinal region and lower limb
C83.86 …… intrapelvic lymph nodes
C83.87 …… spleen
C83.88 …… lymph nodes of multiple sites
C83.89 …… extranodal and solid organ sites

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.